Quarterly report [Sections 13 or 15(d)]

Collaborations, Licensing Agreements and Other Agreements - Additional Information (Details)

v3.26.3
Collaborations, Licensing Agreements and Other Agreements - Additional Information (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
May 31, 2020
Sep. 30, 2026
Sep. 30, 2025
Mar. 31, 2024
Mar. 31, 2023
Sep. 30, 2026
Sep. 30, 2025
Jun. 30, 2026
Jan. 31, 2024
Dec. 31, 2023
Aug. 31, 2023
May 31, 2023
Oct. 07, 2022
Collaborations, Licensing Agreements And Other Agreements [Line Items]                          
Research and development expense   $ 47,144 $ 39,824     $ 128,927 $ 106,480            
Upfront payment                   $ 1,100      
License Agreement                          
Collaborations, Licensing Agreements And Other Agreements [Line Items]                          
Obligation to be paid   2,000       $ 2,000              
Payment term           3 years              
License maintenance fee $ 33         $ 10              
Total milestone payments           21,000              
Amounts due to agreement   0       0              
License Agreement | Maximum                          
Collaborations, Licensing Agreements And Other Agreements [Line Items]                          
Total milestone payments           12,000              
Sponsored Research Agreements                          
Collaborations, Licensing Agreements And Other Agreements [Line Items]                          
Obligation to be paid   12,560       12,560              
Master Translational Research Services Agreement                          
Collaborations, Licensing Agreements And Other Agreements [Line Items]                          
Research and development expense   $ 61 $ 894     990 $ 4,188            
Remaining research and development expense to be incurred           0              
Oxford Biomedica                          
Collaborations, Licensing Agreements And Other Agreements [Line Items]                          
Obligation to be paid                     $ 5,000    
Total milestone payments           500              
Research and development expense           26,000              
Upfront payment                       $ 500  
Expenses           18,868              
Nanjing IASO Biotherapeutics Co., Ltd.                          
Collaborations, Licensing Agreements And Other Agreements [Line Items]                          
Total milestone payments       $ 1,500 $ 1,000 2,500              
Upfront payment               $ 162,000         $ 2,500
Autolus Holdings                          
Collaborations, Licensing Agreements And Other Agreements [Line Items]                          
Upfront payment         $ 1,200       $ 100        
Autolus Holdings | Maximum                          
Collaborations, Licensing Agreements And Other Agreements [Line Items]                          
Total milestone payments           $ 15,000